Start for free
Start for free
The Mark Foundation for Cancer Research logo

The Mark Foundation for Cancer Research

North America, New York, United States, New York

Description

Mark Foundation actively partners with scientists to accelerate research that will transform the prevention, diagnosis, treatment of cancer.

Investor Profile

The Mark Foundation for Cancer Research has made 12 investments, with 0 in the past 12 months and 8% as lead.

Stage Focus

  • Series B (33%)
  • Series A (25%)
  • Seed (17%)
  • Series C (8%)
  • Series Unknown (8%)
  • Grant (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Life Science
  • Biopharma
  • Genetics
  • Health Diagnostics
  • Pharmaceutical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Mark Foundation for Cancer Research frequently co-invest with?

Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Agent Capital
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
NS Investment
NS Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Droia Ventures
Droia Ventures
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 4
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
BrightEdge Fund
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 2
Longwood Fund
Longwood Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
AbbVie Biotech Ventures
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 2

Which angels does The Mark Foundation for Cancer Research often collaborate with?

BA
Bruce A. Peacock
North America, Maryland, United States, Baltimore
Shared Deals: 1
GK
Glen Kacher
North America, California, United States, Palo Alto
Shared Deals: 1

What are some of recent deals done by The Mark Foundation for Cancer Research?

Accent Therapeutics

Lexington, Massachusetts, United States

Accent Therapeutics is a biopharmaceutical company.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CJan 23, 2024
Amount Raised: $75,000,000
Hyku

Lexington, Massachusetts, United States

Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.

BiopharmaBiotechnologyLife Science
SeedSep 19, 2023
Amount Raised: $56,000,000
Vicinitas Therapeutics

San Francisco, California, United States

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

BiotechnologyLife ScienceTherapeutics
Series AJul 28, 2022
Amount Raised: $65,000,000
Immunitas Therapeutics

Cambridge, Massachusetts, United States

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series BAug 18, 2021
Amount Raised: $58,000,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AMay 18, 2021
Amount Raised: $76,000,000
C2i Genomics

New York, New York, United States

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

GeneticsHealth CareHealth DiagnosticsTherapeutics
Series BApr 15, 2021
Amount Raised: $100,000,000
C2i Genomics

New York, New York, United States

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

GeneticsHealth CareHealth DiagnosticsTherapeutics
Series AJun 9, 2020
Amount Raised: $12,000,000
Accent Therapeutics

Lexington, Massachusetts, United States

Accent Therapeutics is a biopharmaceutical company.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BApr 23, 2020
Amount Raised: $63,000,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedMar 13, 2020
Amount Raised: $5,500,000
The Jackson Laboratory

Bar Harbor, Maine, United States

The Jackson Laboratory conducts mammalian genetics research offering scientific services and resources to laboratories and students.

BiotechnologyGeneticsHealth CareMedicalProduct Research
GrantDec 18, 2019
Amount Raised: $2,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator